Page last updated: 2024-11-12
fenicoberan
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
fenicoberan: experimental acid neutralizer in peptic ulcer; exhibits similar therapeutic effects as carbocholen in treatment of ischemic heart disease; exhibits antiarrhytmic properties in patients with extrasystolia; Russian drug; RN given refers to HCl [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 10452131 |
MeSH ID | M0064322 |
Synonyms (23)
Synonym |
---|
fenicoberan |
AKOS005267150 |
EN300-03078 |
51771-50-7 |
ethyl 4-[(dimethylamino)methyl]-5-hydroxy-2-phenyl-1-benzofuran-3-carboxylate hydrochloride |
FT-0684330 |
F0308-0009 |
ethyl 4-((dimethylamino)methyl)-5-hydroxy-2-phenylbenzofuran-3-carboxylate hydrochloride |
phenicaberan hydrochloride |
phenicaberan hydrochloride [who-dd] |
3-benzofurancarboxylic acid, 4-((dimethylamino)methyl)-5-hydroxy-2-phenyl-, ethyl ester, hydrochloride (1:1) |
vinboron |
mfcd00377484 |
2-phenyl-3-ethoxycarbonyl-4-dimethylaminomethyl-5-hydroxybenzofuran hydrochloride |
SR-01000420317-1 |
sr-01000420317 |
Z56813243 |
VS-07506 |
ethyl 4-[(dimethylamino)methyl]-5-hydroxy-2-phenyl-1-benzofuran-3-carboxylate;hydrochloride |
DTXSID50966081 |
ethyl 4-[(dimethylamino)methyl]-5-hydroxy-2-phenyl-1-benzofuran-3-carboxylate--hydrogen chloride (1/1) |
Q27291914 |
CS-0368553 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.68
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.68) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (7.14%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (92.86%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |